Eton Pharmaceuticals' Series A Round

Eton Pharmaceuticals raised a round of funding on June 20, 2017.

Eton Pharmaceuticals was formed by Imprimis Pharmaceuticals, and if focused on the development and commercialization of innovative sterile injectable product candidates utilizing the FDA 505(b)(2) reg…

Articles about Eton Pharmaceuticals' Series A Round: